MeSH D006962 - secondary hyperparathyroidism
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Cinacalcet | Cinacalcet |  | 2020-05-15 |  |  |
| Cinacalcet | Cinacalcet Accordpharma |  | 2020-04-03 |  |  | |
| Alkem Laboratories | Cinacalcet | Cinacalcet |  | 2019-05-17 |  |  |
| Allergan | Cinacalcet | Cinacalcet |  | 2018-12-27 |  |  |
| Amgen | Cinacalcet | Mimpara |  | 2004-10-22 |  |  |
| Etelcalcetide | Parsabiv |  | 2016-11-11 |  |  | |
| Cinacalcet | Sensipar | 2026-09-22 | 2004-03-08 |  |  | |
| Aurobindo Pharma | Cinacalcet | Cinacalcet |  | 2018-03-08 |  |  |
| Chartwell Pharmaceuticals | Cinacalcet | Cinacalcet |  | 2020-05-18 |  |  |
| Cipla | Cinacalcet | Cinacalcet |  | 2018-03-08 |  |  |
| Dr Reddys Laboratories | Cinacalcet | Cinacalcet |  | 2020-09-18 |  |  |
| Hetero | Cinacalcet | Cinacalcet |  | 2020-10-07 |  |  |
| Jerome Stevens Pharmaceuticals | Cinacalcet | Cinacalcet |  | 2021-12-02 |  |  |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
100%5/5
Phase 2
100%12/12
Phase 3
86%12/14
Approved: 3Overall Success rate: 86%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use